Abstract:The multitude of multi-omics data generated cost-effectively using advanced high-throughput technologies has imposed challenging domain for research in Artificial Intelligence (AI). Data curation poses a significant challenge as different parameters, instruments, and sample preparations approaches are employed for generating these big data sets. AI could reduce the fuzziness and randomness in data handling and build a platform for the data ecosystem, and thus serve as the primary choice for data mining and big data analysis to make informed decisions. However, AI implication remains intricate for researchers/clinicians lacking specific training in computational tools and informatics. Cancer is a major cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018. Certain cancers, such as pancreatic and gastric cancers, are detected only after they have reached their advanced stages with frequent relapses. Cancer is one of the most complex diseases affecting a range of organs with diverse disease progression mechanisms and the effectors ranging from gene-epigenetics to a wide array of metabolites. Hence a comprehensive study, including genomics, epi-genomics, transcriptomics, proteomics, and metabolomics, along with the medical/mass-spectrometry imaging, patient clinical history, treatments provided, genetics, and disease endemicity, is essential. Cancer Moonshot℠ Research Initiatives by NIH National Cancer Institute aims to collect as much information as possible from different regions of the world and make a cancer data repository. AI could play an immense role in (a) analysis of complex and heterogeneous data sets (multi-omics and/or inter-omics), (b) data integration to provide a holistic disease molecular mechanism, (c) identification of diagnostic and prognostic markers, and (d) monitor patient's response to drugs/treatments and recovery. AI enables precision disease management well beyond the prevalent disease stratification patterns, such as differential expression and supervised classification. This review highlights critical advances and challenges in omics data analysis, dealing with data variability from lab-to-lab, and data integration. We also describe methods used in data mining and AI methods to obtain robust results for precision medicine from "big" data. In the future, AI could be expanded to achieve ground-breaking progress in disease management.

Artificial intelligence aids in development of nanomedicines for cancer management

Artificial intelligence assists precision medicine in cancer treatment

Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine

Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes

Amalgamation of Artificial Intelligence with Nanoscience for Biomedical Applications

Artificial intelligence-assisted selection and efficacy prediction of antineoplastic strategies for precision cancer therapy.

Evolution of artificial intelligence as a modern technology in advanced cancer therapy

Artificial intelligence in clinical research of cancers

Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction

Application of Computational Biology and Artificial Intelligence Technologies in Cancer Precision Drug Discovery

Intelligent nanomaterials for cancer therapy: recent progresses and future possibilities

The Role of Artificial Intelligence and Machine Learning in Accelerating the Discovery and Development of Nanomedicine

A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine

Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges

Artificial intelligence in nanotechnology for treatment of diseases

Application of Artificial Intelligence in the Exploration and Optimization of Biomedical Nanomaterials

Advances of medical nanorobots for future cancer treatments

Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade

Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision Oncology

Artificial Intelligence in Oncology: The Wins, The Challenges, and How We Can Deliver on Personalized Cancer Care

Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence